Authors: Dawling, S Roodi, N Mernaugh, RL Wang, XH Parl, FF

Citation: S. Dawling et al., Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: Comparison of wild-type and variant COMT isoforms, CANCER RES, 61(18), 2001, pp. 6716-6722

Authors: Carter, BA Page, DL Schuyler, P Parl, FF Simpson, JF Jensen, RA Dupont, WD

Citation: Ba. Carter et al., No elevation in long-term breast carcinoma risk for women with fibroadenomas that contain atypical hyperplasia, CANCER, 92(1), 2001, pp. 30-36

Authors: Ritchie, MD Hahn, LW Roodi, N Bailey, LR Dupont, WD Parl, FF Moore, JH

Citation: Md. Ritchie et al., Multifactor-dimensionality reduction reveals high-order interactions amongestrogen-metabolism genes in sporadic breast cancer, AM J HU GEN, 69(1), 2001, pp. 138-147

Authors: Nass, SJ Herman, JG Gabrielson, E Iversen, PW Parl, FF Davidson, NE Graff, JR

Citation: Sj. Nass et al., Aberrant methylation of the estrogen receptor and E-cadherin 5 ' CpG islands increases with malignant progression in human breast cancer, CANCER RES, 60(16), 2000, pp. 4346-4348

Authors: Hanna, IH Dawling, S Roodi, N Guengerich, FP Parl, FF

Citation: Ih. Hanna et al., Cytochrome P4501B1 (CYP1B1) pharmacogenetics: Association of polymorphismswith functional differences in estrogen hydroxylation activity, CANCER RES, 60(13), 2000, pp. 3440-3444

Authors: Dupont, WD Page, DL Parl, FF Plummer, WD Schuyler, PA Kasami, M Jensen, RA

Citation: Wd. Dupont et al., Estrogen replacement therapy in women with a history of proliferative breast disease, CANCER, 85(6), 1999, pp. 1277-1283